Trials / Completed
CompletedNCT04942353
Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in HeartMate 3 Patients
Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in HeartMate 3TM Patients: A Randomized Controlled Pilot Study (MOVE-LVAD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate that home-based exercise rehabilitation (HER) compared to usual care (UC) results in a significant reduction in healthcare utilization in HeartMate 3 (HM3) left ventricular assist device (LVAD) patients.(defined as rehospitalization, VAD Clinic visits, and ER visits during the 1st year after index discharge following LVAD implantation).
Detailed description
HER Subjects: Get Garmin activity watch (has its own smartphone app to be activated)\*, Datos app Get resistance bands and light weights Exercise prescription: Initially by physical therapist prior to discharge home \& updated every month. UC Subjects: Get Garmin activity watch (has its own smartphone app to be activated), Datos app Exercise prescription: Try to get to 30 min of exercise 5 days a week
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Home-based Exercise Rehabilitation. | Based on physical therapist or exercise physiologist assessment, subjects will receive an individualized exercise prescription for frequency, duration, and intensity of walking and strength training (including exercises using light-weight hand-weights and upper and lower body exercises using resistance bands). Research team will provide updated exercise prescription based on Garmin watch/Datos app activity data and Datos app data (including Borg scale). |
| BEHAVIORAL | Usual Care | Patients receive a standardized recommendation to increase their walking activity to 30 minutes 5 days/week. |
Timeline
- Start date
- 2020-10-19
- Primary completion
- 2023-04-17
- Completion
- 2023-04-17
- First posted
- 2021-06-28
- Last updated
- 2023-11-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04942353. Inclusion in this directory is not an endorsement.